COVID-19疫苗接种后获得性血友病A一例报告
本文报告一例69岁男性在接种COVID-19疫苗后出现出血症状,实验室检查示活化部分凝血活酶时间孤立性延长、血管性血友病因子正常,进一步检查确认存在凝血因子VIII抑制物。截至报告时,尚无COVID-19疫苗接种后发生获得性血友病A的报道,作者汇总了流感疫苗、H1N1疫苗及COVID-19感染后获得性血友病A的相关病例并综述疫苗接种后自身免疫反应文献。
要点
- 接种COVID-19疫苗后出现出血症状需警惕获得性血友病A。
- 活化部分凝血活酶时间孤立性延长伴血管性血友病因子正常时应检测凝血因子VIII抑制物。
- 本文为单个病例报告,因果关系尚不能确定。
核心结论
- 报告一例69岁男性接种COVID-19疫苗后发生获得性血友病A,截至报告时此类病例尚无既往报道。
研究设计与样本
- 单例病例报告,并汇总既往流感疫苗、H1N1疫苗及COVID-19感染后获得性血友病A病例并综述文献。
主要发现
- 患者69岁男性,接种COVID-19疫苗后出现出血症状,活化部分凝血活酶时间孤立性延长,血管性血友病因子正常,确认存在凝血因子VIII抑制物。
- 既往有季节性流感疫苗和H1N1疫苗接种后获得性血友病A各两例,以及COVID-19感染后获得性血友病A两例。
临床怎么用
- 接种COVID-19疫苗后出现出血且活化部分凝血活酶时间孤立性延长时,应考虑检测凝血因子VIII抑制物以排查获得性血友病A。
局限性
- 为单例病例报告,无法确立疫苗接种与获得性血友病A之间的因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acquires hemophilia A (AHA) is rare bleeding condition commonly associated with malignancy, autoimmune disease, or pregnancy. We report a case of a 69-year-old gentleman who developed bleeding symptoms after receiving COVID-19 vaccine. Laboratory testing showed isolated prolongation of the activated partial thromboplastin time, and normal von Willebrand factor. Further testing confirmed the presence of factor VIII inhibitor. To date, no cases of AHA have been reported after exposure to COVID-19 vaccine. There have been two cases of AHA following seasonal flu and H1N1 vaccination, as well as two cases of AHA following COVID-19 infection. We present a summary of these cases and review of literature of autoimmune reactions following vaccination.
引用
- Radwi M, Farsi S. A case report of acquired hemophilia following COVID-19 vaccine. J Thromb Haemost. 2021. PMID: 33783953. doi:10.1111/jth.15291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。